Facebook Twitter LinkedIn Google Plus RSS

Pfizer top pharma firm on Fortune 500

By ,

Three New Jersey-based life sciences firms made the latest Fortune 500, but Pfizer Inc. remains top dog in the industry.

The annual list ranks the world’s largest companies by revenue and provides a good look at how the top Big Pharma firms stack up against each other.

Exxon Mobil leapfrogged Walmart for the top spot on the overall list after raking in $452.9 billion in 2011.

Within pharma, Pfizer remains the biggest firm, coming in at No. 40 after bringing in $67.9 billion in revenue last year. The company is based in New York, but has a large presence in the Garden State.


  • New Brunswick-based Johnson & Johnson checked in at No. 42 on the strength of $65 billion in profits.
  • Whitehouse Station-based Merck & Co. was at No. 57. It brought in $48 billion last year.
  • Bristol-Myers Squibb, which had $21.2 billion in profits, came in at No. 134. Like Pfizer, BMS is based in New York but has a heavy New Jersey footprint.
  • Finally, Celgene Corp., the Summit-based biotech giant, cracked the Fortune 500 with its No. 492 ranking. The company saw its revenues jump 33.5 percent last year versus 2010, with a total of $4.8 billion.

With the exception of Celgene, the local pharma firms all slid in this year's list. The largest drop was Pfizer, which had been No. 31 last year.

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy